NCT01161082View on ClinicalTrials.gov

Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Hypercholesterolemia

Interventions

DRUG

REGN727(SAR236553)

subcutaneous

Trial Locations (2)

Unknown

Site 1, Cincinnati

Site 2, Knoxville

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY